Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Diosmetin-7-O-β-D-glucopyranoside

Copy Product Info
😃Good
Catalog No. T4S0692Cas No. 20126-59-4
Alias Eridictiol, Diosmetin-7-O-beta-D-glucopyranoside

Diosmetin-7-O-β-D-glucopyranoside (Eridictiol) exhibits antioxidant activity.

Diosmetin-7-O-β-D-glucopyranoside

Diosmetin-7-O-β-D-glucopyranoside

Copy Product Info
😃Good
Purity: 99.44%
Catalog No. T4S0692Alias Eridictiol, Diosmetin-7-O-beta-D-glucopyranosideCas No. 20126-59-4
Diosmetin-7-O-β-D-glucopyranoside (Eridictiol) exhibits antioxidant activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$68In StockIn Stock
2 mg$98In StockIn Stock
5 mg$163In StockIn Stock
10 mg$272In StockIn Stock
25 mg$458In StockIn Stock
50 mg$663In StockIn Stock
100 mg$927-In Stock
200 mg$1,230-In Stock
1 mL x 10 mM (in DMSO)$166In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.44%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Diosmetin-7-O-β-D-glucopyranoside AI Summary
Diosmetin-7-O-β-D-glucopyranoside demonstrates a diverse range of bioactivities, particularly as an inhibitor of various enzymes. It exhibits an inhibitory effect on cow milk xanthine oxidase with an inhibition rate of 28.9% at 50 µg/mL, indicating potential in xanthine oxidase inhibition. The compound also inhibits the human IDH1 R132H mutant and human IDH1 enzyme activity in vitro with inhibition levels of 111.5% and 107.5% in specific enzyme assays involving NADPH and NADP+. In addition, it shows bioactivity as an LSD1 inhibitor with an IC50 value of 21,830 nM, demonstrating moderate potency. Against the human recombinant full-length PTP1B enzyme, Diosmetin-7-O-β-D-glucopyranoside displays inhibition percentages of 27.74%, 23.36%, and 29.79% at 1 µM, 5 µM, and 10 µM, respectively. However, it demonstrates weak inhibitory activity against baker's yeast alpha-glucosidase with an IC50 value exceeding 100,000 nM. Furthermore, the compound exhibits anti-inflammatory properties by decreasing PGE2 production in LPS-stimulated mouse RAW264.7 cells, though its potency is relatively low with an IC50 value greater than 50,000 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Diosmetin-7-O-β-D-glucopyranoside (Eridictiol) exhibits antioxidant activity.
SynonymsEridictiol, Diosmetin-7-O-beta-D-glucopyranoside
Chemical Properties
Molecular Weight462.4
FormulaC22H22O11
Cas No.20126-59-4
SmilesCOc1ccc(cc1O)-c1cc(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2o1
Relative Density.1.609 g/cm3
Storage & Solubility Information
Storagekeep away from direct sunlight | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (97.32 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1626 mL10.8131 mL21.6263 mL108.1315 mL
5 mM0.4325 mL2.1626 mL4.3253 mL21.6263 mL
10 mM0.2163 mL1.0813 mL2.1626 mL10.8131 mL
20 mM0.1081 mL0.5407 mL1.0813 mL5.4066 mL
50 mM0.0433 mL0.2163 mL0.4325 mL2.1626 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Diosmetin-7-O-β-D-glucopyranoside | purchase Diosmetin-7-O-β-D-glucopyranoside | Diosmetin-7-O-β-D-glucopyranoside cost | order Diosmetin-7-O-β-D-glucopyranoside | Diosmetin-7-O-β-D-glucopyranoside chemical structure | Diosmetin-7-O-β-D-glucopyranoside formula | Diosmetin-7-O-β-D-glucopyranoside molecular weight